<html xmlns:v="urn:schemas-microsoft-com:vml" xmlns:o="urn:schemas-microsoft-com:office:office" xmlns:w="urn:schemas-microsoft-com:office:word" xmlns:m="http://schemas.microsoft.com/office/2004/12/omml" xmlns="http://www.w3.org/TR/REC-html40">
<head>
<meta http-equiv=Content-Type content="text/html; charset=us-ascii">
<meta name=Generator content="Microsoft Word 12 (filtered medium)">
<style>
<!--
/* Font Definitions */
@font-face
{font-family:"Cambria Math";
panose-1:2 4 5 3 5 4 6 3 2 4;}
@font-face
{font-family:Calibri;
panose-1:2 15 5 2 2 2 4 3 2 4;}
@font-face
{font-family:Verdana;
panose-1:2 11 6 4 3 5 4 4 2 4;}
/* Style Definitions */
p.MsoNormal, li.MsoNormal, div.MsoNormal
{margin:0in;
margin-bottom:.0001pt;
font-size:11.0pt;
font-family:"Calibri","sans-serif";}
a:link, span.MsoHyperlink
{mso-style-priority:99;
color:blue;
text-decoration:underline;}
a:visited, span.MsoHyperlinkFollowed
{mso-style-priority:99;
color:purple;
text-decoration:underline;}
p
{mso-style-priority:99;
mso-margin-top-alt:auto;
margin-right:0in;
mso-margin-bottom-alt:auto;
margin-left:0in;
font-size:12.0pt;
font-family:"Times New Roman","serif";}
pre
{mso-style-priority:99;
mso-style-link:"HTML Preformatted Char";
margin:0in;
margin-bottom:.0001pt;
font-size:10.0pt;
font-family:"Courier New";}
span.EmailStyle17
{mso-style-type:personal-compose;
font-family:"Calibri","sans-serif";
color:windowtext;}
span.HTMLPreformattedChar
{mso-style-name:"HTML Preformatted Char";
mso-style-priority:99;
mso-style-link:"HTML Preformatted";
font-family:"Courier New";}
.MsoChpDefault
{mso-style-type:export-only;}
@page WordSection1
{size:8.5in 11.0in;
margin:1.0in 1.0in 1.0in 1.0in;}
div.WordSection1
{page:WordSection1;}
-->
</style>
<!--[if gte mso 9]><xml>
<o:shapedefaults v:ext="edit" spidmax="1026" />
</xml><![endif]--><!--[if gte mso 9]><xml>
<o:shapelayout v:ext="edit">
<o:idmap v:ext="edit" data="1" />
</o:shapelayout></xml><![endif]-->
</head>
<body lang=EN-US link=blue vlink=purple>
<div class=WordSection1>
<p class=MsoNormal>Senator Amy Klobuchar’s Secure and Responsible Drug
Disposal Act of 2010 passed the Senate yesterday! The purpose of this bill is
to amend the Controlled Substances Act to facilitate drug take-back.<o:p></o:p></p>
<p class=MsoNormal><o:p> </o:p></p>
<p class=MsoNormal>HR 5809, the House bill with the same goal, passed the
Energy and Commerce Committee in late July. Watch for it to go to the House
floor in September!<o:p></o:p></p>
<p class=MsoNormal><o:p> </o:p></p>
<p class=MsoNormal>Update on Senate bill:<o:p></o:p></p>
<p class=MsoNormal><o:p> </o:p></p>
<p class=MsoNormal>http://www.opencongress.org/bill/111-s3397/show<o:p></o:p></p>
<p class=MsoNormal><o:p> </o:p></p>
<p class=MsoNormal><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'><o:p> </o:p></span></p>
<p class=MsoNormal><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>_____________________________<o:p></o:p></span></p>
<p class=MsoNormal><b><i><span style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>Sierra E. Fletcher</span></i></b><span style='font-size:10.0pt;
font-family:"Verdana","sans-serif";color:black'><o:p></o:p></span></p>
<p class=MsoNormal><span style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>Director of Policy and Programs<o:p></o:p></span></p>
<p class=MsoNormal><i><span style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>Product Stewardship Institute, Inc.<o:p></o:p></span></i></p>
<p class=MsoNormal><span style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>29 Stanhope St., 3rd Floor<o:p></o:p></span></p>
<p class=MsoNormal><span style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>Boston, MA 02116<o:p></o:p></span></p>
<p class=MsoNormal><span style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>617-236-4886 (phone)<o:p></o:p></span></p>
<p class=MsoNormal><span style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>sierra@productstewardship.us<o:p></o:p></span></p>
<p class=MsoNormal><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'><a
href="http://www.productstewardship.us/"><span style='color:blue'>www.productstewardship.us</span></a><o:p></o:p></span></p>
<p class=MsoNormal><b><span style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#548DD4'><o:p> </o:p></span></b></p>
<p class=MsoNormal><b><span style='color:gray'>Click to follow us on </span></b><b><span
style='color:#4F81BD'><a
href="http://www.facebook.com/pages/Product-Stewardship-Institute/224328115936?ref=ts"><span
style='color:#4F81BD'>Facebook</span></a></span></b><b><span style='color:gray'>
and </span></b><b><span style='color:#4F81BD'><a
href="http://twitter.com/productsteward"><span style='color:#4F81BD'>Twitter</span></a></span></b><b><span
style='color:gray'><o:p></o:p></span></b></p>
<p class=MsoNormal><b><span style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#548DD4'><o:p> </o:p></span></b></p>
<p>S. 3397 <o:p></o:p></p>
<p> <em> Be it enacted by the Senate and House of
Representatives of the United States of America in Congress assembled,</em><o:p></o:p></p>
<p> <b>SECTION 1. SHORT TITLE.</b><o:p></o:p></p>
<p> This Act may be cited as the ``Secure and Responsible
Drug Disposal Act of 2010''.<o:p></o:p></p>
<p> <b>SEC. 2. FINDINGS.</b><o:p></o:p></p>
<p> Congress finds the following:<o:p></o:p></p>
<p> (1) The nonmedical use of prescription drugs is a growing
problem in the United States, particularly among teenagers.<o:p></o:p></p>
<p> (2) According to the Department of Justice's 2009
National Prescription Drug Threat Assessment--<o:p></o:p></p>
<p> (A) the number of deaths and treatment admissions for
controlled prescription drugs (CPDs) has increased significantly in recent
years;<o:p></o:p></p>
<p> (B) unintentional overdose deaths involving prescription
opioids, for example, increased 114 percent from 2001 to 2005, and the number
of treatment admissions for prescription opioids increased 74 percent from 2002
to 2006; and<o:p></o:p></p>
<p> (C) violent crime and property crime associated with
abuse and diversion of CPDs has increased in all regions of the United States
over the past 5 years.<o:p></o:p></p>
<p> (3) According to the Office of National Drug Control
Policy's 2008 Report ``Prescription for Danger'', prescription drug abuse is
especially on the rise for teens--<o:p></o:p></p>
<p> (A) one-third of all new abusers of prescription drugs in
2006 were 12- to 17-year-olds;<o:p></o:p></p>
<p> (B) teens abuse prescription drugs more than any illicit
drug except marijuana--more than cocaine, heroin, and methamphetamine combined;
and<o:p></o:p></p>
<p> (C) responsible adults are in a unique position to reduce
teen access to prescription drugs because the drugs often are found in the
home.<o:p></o:p></p>
<p> (4)(A) Many State and local law enforcement agencies have
established drug disposal programs (often called ``take-back'' programs) to
facilitate the collection and destruction of unused, unwanted, or expired
medications. These programs help get outdated or unused medications off
household shelves and out of the reach of children and teenagers.<o:p></o:p></p>
<p> (B) However, take-back programs often cannot dispose of
the most dangerous pharmaceutical drugs--controlled substance
medications--because Federal law does not permit take-back programs to accept
controlled substances unless they get specific permission from the Drug
Enforcement Administration and arrange for full-time law enforcement officers
to receive the controlled substances directly from the member of the public who
seeks to dispose of them.<o:p></o:p></p>
<p> (C) Individuals seeking to reduce the amount of unwanted
controlled substances in their household consequently have few disposal options
beyond discarding or flushing the substances, which may not be appropriate
means of disposing of the substances.<o:p></o:p></p>
<p> (D) Long-term care facilities face a distinct set of obstacles
to the safe disposal of controlled substances due to the increased volume of
controlled substances they handle.<o:p></o:p></p>
<p> (5) This Act gives the Attorney General authority to
promulgate new regulations, within the framework of the Controlled Substances Act,
that will allow patients to deliver unused pharmaceutical controlled substances
to appropriate entities for disposal in a safe and effective manner consistent
with effective controls against diversion.<o:p></o:p></p>
<p> (6) The goal of this Act is to encourage the Attorney
General to set controlled substance diversion prevention parameters that will
allow public and private entities to develop a variety of methods of collection
and disposal of controlled substances in a secure and responsible manner. <o:p></o:p></p>
<pre style='text-align:center'>[Page: S6667] <b><a
href="http://frwebgate.access.gpo.gov/cgi-bin/getpage.cgi?dbname=2010_record&page=S6667&position=all"> <cite><span
style='font-family:"Courier New";color:blue'>GPO's PDF</span></cite></a></b><o:p></o:p></pre>
<p> <b>SEC. 3. DELIVERY OF CONTROLLED SUBSTANCES BY ULTIMATE
USERS FOR DISPOSAL.</b><o:p></o:p></p>
<p> (a) <em>Regulatory Authority</em>.--Section 302 of the
Controlled Substances Act (21 U.S.C. 822) is amended by adding at the end the
following:<o:p></o:p></p>
<p> ``(g)(1) An ultimate user who has lawfully obtained a
controlled substance in accordance with this title may, without being
registered, deliver the controlled substance to another person for the purpose
of disposal of the controlled substance if--<o:p></o:p></p>
<p> ``(A) the person receiving the controlled substance is
authorized under this title to engage in such activity; and<o:p></o:p></p>
<p> ``(B) the disposal takes place in accordance with regulations
issued by the Attorney General to prevent diversion of controlled substances.<o:p></o:p></p>
<p> ``(2) In developing regulations under this subsection,
the Attorney General shall take into consideration the public health and
safety, as well as the ease and cost of program implementation and
participation by various communities. Such regulations may not require any
entity to establish or operate a delivery or disposal program.<o:p></o:p></p>
<p> ``[(2)]<em>(3)</em> The Attorney General may, by
regulation, authorize long-term care facilities, as defined by the Attorney
General by regulation, to dispose of controlled substances on behalf of
ultimate users <em>who reside, or have resided, at such long-term care
facilities</em> in a manner that the Attorney General determines will provide
effective controls against diversion and be consistent with the public health
and safety.<o:p></o:p></p>
<p> ``(4) If a person dies while lawfully in possession of a
controlled substance for personal use, any person lawfully entitled to dispose
of the decedent's property may deliver the controlled substance to another
person for the purpose of disposal under the same conditions as provided in
paragraph (1) for an ultimate user.''.<o:p></o:p></p>
<p> (b) <em>Conforming Amendment</em>.--Section 308(b) of the
Controlled Substances Act (21 U.S.C. 828(b)) is amended--<o:p></o:p></p>
<p> (1) by striking the period at the end of paragraph (2)
and inserting ``; or''; and<o:p></o:p></p>
<p> (2) by adding at the end the following:<o:p></o:p></p>
<p> ``(3) the delivery of such a substance for the purpose of
disposal by an ultimate user or long-term care facility acting in accordance
with section 302(g) of this title.''.<o:p></o:p></p>
<p> <b>SEC. 4. DIRECTIVE TO THE UNITED STATES SENTENCING
COMMISSION.</b><o:p></o:p></p>
<p> Pursuant to its authority under section 994 of title 28,
United States Code, the United States Sentencing Commission shall review and,
if appropriate, amend the Federal sentencing guidelines and policy statements
to ensure that the guidelines and policy statements provide an appropriate
penalty increase of up to 2 offense levels above the sentence otherwise
applicable in Part D of the Guidelines Manual if a person is convicted of a
drug offense resulting from the authorization of that person to receive
scheduled substances from an ultimate user or long-term care facility as set
forth in the amendments made by section 3.<o:p></o:p></p>
<p class=MsoNormal><o:p> </o:p></p>
<p class=MsoNormal><o:p> </o:p></p>
</div>
</body>
</html>